Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Type 1 Diabetes Mellitus (T1DM)
100%
Type I Diabetes
70%
Diabetes
52%
Insulin
47%
Type 2 Diabetes Mellitus (T2DM)
44%
Hypoglycemia
36%
Glucose Transporter 1 (GLUT1)
35%
Children with Type 1 Diabetes
35%
Glucose Transporter 4 (GLUT4)
28%
Hemoglobin A1c (HbA1c)
26%
Metformin
24%
Glycemic Control
24%
Sheep
24%
Diabetes Complications
23%
Diabetes Prevention Program
22%
Wolfram Syndrome
22%
Diabetes Control
21%
Glucagon
20%
Adolescent Diabetes
19%
Insulin Resistance
19%
Young children
18%
Severe Hypoglycemia
18%
Pre-diabetes (pre-DM)
17%
Treatment Options
17%
Developmental Programming
17%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
17%
Diabetes Mellitus
16%
Hyperglycemia
16%
Transgenic Mice
15%
HIV Protease Inhibitors
15%
Insulin Requirement
14%
Risk Factors
14%
X-linked Hypophosphatemia
14%
Glucose Transport
14%
Beta-catenin
14%
Diabetes Epidemiology
13%
Diabetes Intervention
13%
Insulin Sensitivity
13%
Protease Inhibitors
13%
Retinopathy
12%
Overexpressing
12%
Older Adults
12%
Youth Studies
11%
Diabetic Ketoacidosis
11%
Blood Glucose
11%
Diabetes Duration
10%
Cystic Fibrosis
10%
Plasma Glucose
10%
Pediatric
10%
Liver
10%
Hypertension
10%
Metabolic Control
10%
Program Outcomes
10%
Treatment Group
10%
Parental Diabetes
9%
Burosumab
9%
Family Systems Therapy
9%
Early-onset Type 2 Diabetes
9%
Skeletal muscle
9%
Intensive Care Medicine
9%
Testosterone
9%
Diabetes Management
9%
Cell Function
9%
Insulin Secretion
8%
High-fat Diet
8%
Diabetic Retinopathy
8%
Glucose Level
8%
Brain Development
8%
Obesity
8%
Non-diabetic
8%
Cardiovascular Disease
8%
Diabetic
8%
Placebo
7%
Lipids
7%
Clinical Trials
7%
Insulin-dependent Diabetes
7%
Insulin Therapy
7%
Diabetic children
7%
Conventional Therapy
7%
Syndromic Diabetes
7%
Glucose Homeostasis
7%
Lyase
7%
Puberty
7%
Nocturnal Hypoglycemia
7%
Hyperinsulinemia
6%
Facilitative Glucose Transporter
6%
Obesogenic Diet
6%
Body Mass Index
6%
Endoplasmic Reticulum Stress (ER stress)
6%
Non-alcoholic Fatty Liver Disease (NAFLD)
6%
Hepatocytes
6%
Continuous Glucose Monitoring
6%
Liver Regeneration
6%
Control Subjects
6%
Hypophosphatasia
6%
Sexually Dimorphic
6%
Conscious Dogs
6%
Overexpression
6%
Oral Glucose Tolerance Test
6%
Randomized Controlled Trial
6%
Medicine and Dentistry
Insulin Dependent Diabetes Mellitus
80%
Diabetes
78%
Adolescence
41%
Glucose
41%
Maturity Onset Diabetes of the Young
38%
Insulin
36%
Hypoglycemia
30%
Diabetes Mellitus
24%
Glycon
21%
Pediatrics
21%
Diabetes Prevention
21%
Hemoglobin A1c
17%
Diabetes Control and Complications Trial
17%
Offspring
16%
Diseases
15%
Diabetes in Adolescents
15%
Treatment Option
15%
Hyperglycemia
14%
X Linked Hypophosphatemic Rickets
13%
Retinopathy
13%
Severe Hypoglycemia
13%
Glycemic
13%
Glycemic Control
13%
Epidemiology of Diabetes
12%
Insulin Resistance
11%
Wolfram Syndrome
10%
Body Mass Index
10%
Intensive Care
10%
Glucagon
10%
Diabetic Retinopathy
9%
Cystic Fibrosis
9%
Burosumab
9%
Cardiovascular System
9%
Hypertension
9%
Prevalence
9%
Insulin Sensitivity
8%
Cardiovascular Disease
7%
Testosterone
7%
Cell Function
7%
Treatment Group
7%
Diabetic Ketoacidosis
7%
Genetics
7%
Oral
7%
Hyperinsulinemia
7%
Nocturnal Hypoglycemia
6%
Research Design
6%
Insulin Release
6%
C-Peptide
6%
Clinical Trial
6%
Rickets
6%
Impaired Glucose Tolerance
6%
Adipose Tissue
6%
Injection
6%
Vitamin D
6%
Lifestyle Intervention
5%
Glucose Uptake
5%
Oral Glucose Tolerance Test
5%
Adverse Event
5%
Obesogenic Diet
5%
Placebo
5%
Hyperandrogenism
5%
Metabolic Regulation
5%
Nonalcoholic Fatty Liver
5%
Pediatrics Patient
5%
Epinephrine
5%
Glucose Tolerance
5%